Cormedix Earnings Report Overview
Cormedix (NASDAQ: CRMD) is getting ready to announce its quarterly earnings on an upcoming Wednesday. Investors should prepare themselves with essential information before this important event.
Analysts are predicting that Cormedix will report an earnings per share (EPS) of $-0.10. Market watchers will be eager to see whether the company will outperform this estimate and, importantly, provide positive guidance for the following quarter.
For new investors, it's vital to understand that sometimes the stock price's fluctuation hinges not only on whether an earnings beat or miss occurs but significantly on the accompanying guidance and forecasts shared by the company.
Earnings History Overview
In its last earnings release, Cormedix missed the EPS target by $0.00, resulting in a 2.54% decline in share price during the subsequent trading session.
Let’s review Cormedix's recent performance and share price movements:
Quarterly Performance Summary
- EPS Estimate for Q2 2024: -0.25
- EPS Actual for Q2 2024: -0.25
- Price Change % after Q2 2024: -3.0%
- EPS Estimate for Q1 2024: -0.28
- EPS Actual for Q1 2024: -0.25
- Price Change % after Q1 2024: -4.0%
- EPS Estimate for Q4 2023: -0.20
- EPS Actual for Q4 2023: -0.26
- Price Change % after Q4 2023: +14.0%
- EPS Estimate for Q3 2023: -0.21
- EPS Actual for Q3 2023: -0.17
- Price Change % after Q3 2023: +6.0%
Examining Cormedix's Stock Performance
As of the end of October, Cormedix shares were trading at $13.59. Over the last year, stocks have skyrocketed, experiencing a remarkable increase of 282.91%. This strong performance suggests that long-term investors are likely feeling positive as they approach the upcoming earnings announcement.
For those looking to monitor all upcoming earnings reports for Cormedix, visit the earnings calendar hosted on their website.
Frequently Asked Questions
When will Cormedix report its earnings?
Cormedix is scheduled to release its earnings on an upcoming Wednesday.
What is the expected EPS for Cormedix?
The estimated earnings per share (EPS) for Cormedix is $-0.10.
How did Cormedix perform in its last earnings report?
In the last report, Cormedix missed its EPS estimate by $0.00, resulting in a price drop of 2.54% in the next trading session.
What was Cormedix's stock performance over the past year?
Cormedix shares have experienced a significant rise of 282.91% over the last 52 weeks.
What factors influence stock price fluctuations around earnings reports?
While earnings beats or misses play a role, the guidance provided by the company often has a more substantial impact on the stock price.